Ultrasound Measurements Hamstring Muscles Thickness

May 30, 2022 updated by: Josep C. Benitez Martinez, University of Valencia

Ultrasound Measurements of Hamstring Muscles Thickness Are a Valid Tool

No previous studies have compared the association between muscle thickness (MT) and muscle cross-sectional area (CSA) in healthy volunteers. The main aim of this study is to investigate the validity of ultrasound in assessing the muscle thickness of hamstrings muscle.

Study design:

A cross-sectional-validity study.

Setting:

University

Participants:

X football players of an amateur football team (X healthy volunteers and X patients with a previous hamstring injury).

Study Overview

Status

Withdrawn

Detailed Description

X healthy volunteers, from an amateur football team, and X football players with previous history of hamstring injury from an orthopaedic clinic, comprised the subjects in this study. Hamstring muscle injury was defined as "a traumatic distraction or overuse injury to the hamstring muscle leading to a player being unable to fully participate in training or match play".

The Control Group (CG) were healthy, had neither surgery/trauma in their lower extremities, nor history of hamstring injury, and there were no abnormal findings in their physical examination. The exclusion criteria included participants who: (1) had metal implants or pace makers, (2) weighted more than 200 kg (MRI table limitations), and (3) were unable to complete testing. In the Injured Group, patients were also excluded if their previous injury was originated from a non-muscular source (e.g., inguinal or femoral hernia, nerve entrapment, lumbosacral pathology), or if still had symptoms, had not returned to practice and had not been participating in track and field since their last injury.

The Study Group (SG) had history and diagnosis of hamstring injury assessment with diagnosis image technique (ultrasound or MRI), and at least 2 of the next criteria: 1. When the injury happened disability to practise with the team at least one week; 2. Lost at least one match; 3. Felt pain when trying to kick the ball or run fast; 4. Receive specific treatment (medical or physiotherapy) for the injury; 5. Needed a period plan to return to play.

Participants were screened for contraindications to MRI before ultrasound assessment and an MRI scan of the hamstring muscles of both legs were performed. MRI was performed within 24 h of the ultrasound scan. The subjects were instructed not to consume alcohol or perform any moderate to heavy exercise for 24 hours prior to each imaging session.

Muscle thickness was defined as the distance between the bone-muscle interface and the adipose tissue-muscle interface. The measurement was made from the most superficial edge of the bright line representing the interface of the bony cortex and the muscle to the most superficial edge of the bright line representing the interface of the outer fascial layer of the muscle and the subcutaneous adipose tissue. When the bone was not in contact of the muscle the two fascial layer were used.

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers from an amateur soccer team

Description

Inclusion Criteria:

  • Practice at least twice per week
  • Playing soccer more than 5 years
  • Inform Consent signed

Exclusion Criteria:

  • 18 years or older
  • Had metal implants or pace makers
  • Weighted more than 200 kg (MRI table limitations)
  • Were unable to complete testing

Injuries players:

  • History and diagnosis of hamstring injury
  • Assessment with diagnosis image technique (ultrasound or MRI)
  • At least 2 of the next criteria:

    1. When the injury happened disability to practise with the team at least one week;
    2. Lost at least one match
    3. Felt pain when trying to kick the ball or run fast
    4. Receive specific treatment (medical or physiotherapy) for the injury
    5. Needed a period plan to return to play

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Hamstring muscles thickness in millimeters by Ultrasound
Time Frame: 30 minutes
30 minutes
Hamstring muscles thickness in millimeters by Magnetic Resonance Image
Time Frame: 1 hour
1 hour

Secondary Outcome Measures

Outcome Measure
Time Frame
Cross-Sectional Area of the hamstring muscles in square millimeters by Ultrasound
Time Frame: 30 minutes
30 minutes
Cross-Sectional Area of the hamstring muscles in square millimeters by Magnetic Resonance Image
Time Frame: 1 hour
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Josep Benítez-Martínez, University of Valencia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Actual)

April 26, 2021

Study Completion (Anticipated)

February 15, 2022

Study Registration Dates

First Submitted

November 2, 2016

First Submitted That Met QC Criteria

November 4, 2016

First Posted (Estimate)

November 8, 2016

Study Record Updates

Last Update Posted (Actual)

June 2, 2022

Last Update Submitted That Met QC Criteria

May 30, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Atrophy

3
Subscribe